Kiromic BioPharma
$10.079876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$10.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.78 (-7.19%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell KRBP and other stocks, options, and ETFs commission-free!
About KRBP
Kiromic Biopharma, Inc. operates as a biotechnology company, which engages in the development of cancer engineered immunotherapies. Its technologies include Intelligent Immunotherapy, Diamond AI, CancerSplice, ABBIE, and CAR-T Proprietary Binder Technology. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX. The listed name for KRBP is Kiromic BioPharma, Inc. Common Stock.
CEO
Maurizio Chiriva-Internati
Employees
—
Headquarters
Houston, Texas
Founded
2006
Market Cap
50.28M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
30.71K
High Today
$10.94
Low Today
$9.93
Open Price
$10.90
Volume
46.59K
52 Week High
$18.50
52 Week Low
$8.01
KRBP Earnings
-$0.65
-$0.43
-$0.22
$0.00
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours